WPI 2510 (Budesonide Extended-Release 9 mg)

Pill with imprint WPI 2510 is White, Round and has been identified as Budesonide Extended-Release 9 mg. It is supplied by Actavis Pharma, Inc.

Budesonide is used in the treatment of crohn's disease; asthma, maintenance; crohn's disease, acute; inflammatory bowel disease; crohn's disease, maintenance and belongs to the drug classes glucocorticoids, inhaled corticosteroids. Risk cannot be ruled out during pregnancy. Budesonide 9 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 2510

Imprint: WPI 2510
Strength: 9 mg
Color: White
Size: 9.00 mm
Shape: Round
Availability: Prescription only
Drug Class: Glucocorticoids, Inhaled corticosteroids
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: Actavis Pharma, Inc.
National Drug Code (NDC): 00591-2510
Inactive Ingredients: silicon dioxide, hypromellose 2910 (3 mPa.s), hypromellose 2910 (6 mPa.s), ferrosoferric oxide, lactose monohydrate, magnesium stearate, methacrylic acid - methyl methacrylate copolymer (1:1), methacrylic acid - methyl methacrylate copolymer (1:2), microcrystalline cellulose, polyethylene glycol 400, polysorbate 80, propylene glycol, sodium starch glycolate type A potato, soya lecithin, magnesium silicate, titanium dioxide, triethyl citrate
Note: Inactive ingredients may vary.

Other brands: Pulmicort Turbuhaler, Pulmicort Flexhaler, Entocort EC, Pulmicort Respules, ... +4 more

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.